Get the Stockscreener App
1.45
2.03%
-0.03
After Hours:
1.46
0.01
+0.69%
Maxcyte Inc stock is traded at $1.45, with a volume of 476.33K.
It is down -2.03% in the last 24 hours and up +14.17% over the past month.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
See More
Previous Close:
$1.48
Open:
$1.49
24h Volume:
476.33K
Relative Volume:
0.60
Market Cap:
$154.58M
Revenue:
$45.44M
Net Income/Loss:
$-35.43M
P/E Ratio:
-4.2647
EPS:
-0.34
Net Cash Flow:
$-25.39M
1W Performance:
+2.84%
1M Performance:
+14.17%
6M Performance:
-54.40%
1Y Performance:
-63.75%
1-Day Range:
$1.415
$1.49
1-Week Range:
$1.38
$1.49
52-Week Range:
$1.26
$5.20
Maxcyte Inc Stock (MXCT) Company Profile
Name
Maxcyte Inc
Sector
Industry
Phone
301-517-5556
Address
9713 KEY WEST AVENUE,, ROCKVILLE
Compare MXCT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MXCT
Maxcyte Inc
|
1.45 | 151.38M | 45.44M | -35.43M | -25.39M | -0.34 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Maxcyte Inc Stock (MXCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-25 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-22-25 | Initiated | Stephens | Overweight |
| Nov-29-23 | Initiated | Craig Hallum | Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-24-21 | Initiated | BTIG Research | Buy |
| Aug-24-21 | Initiated | Cowen | Outperform |
| Aug-24-21 | Initiated | Stephens | Overweight |
| Aug-24-21 | Initiated | Stifel | Buy |
| Aug-24-21 | Initiated | Wedbush | Outperform |
| Aug-24-21 | Initiated | William Blair | Outperform |
View All
Maxcyte Inc Stock (MXCT) Latest News
MaxCyte Inc. stock outlook for YEAR2025 Technical Overview & Real-Time Market Sentiment Alerts - Newser
Is now the right time to enter MaxCyte Inc.Weekly Trend Summary & Stepwise Entry and Exit Trade Signals - Lancaster City Council
Will MaxCyte Inc. rebound enough to break evenTrade Volume Report & AI Powered Buy/Sell Recommendations - Newser
Can MaxCyte Inc. disrupt its industryWeekly Trend Recap & AI Forecasted Entry and Exit Points - beatles.ru
MaxCyte, Inc. (NASDAQ:MXCT) Q4 2024 Earnings Call Transcript - MSN
268,541 Shares in MaxCyte, Inc. $MXCT Purchased by Nuveen LLC - MarketBeat
What is the PEG ratio of MaxCyte Inc.Quarterly Market Summary & Safe Entry Zone Identification - 뉴스영
Historical volatility pattern of MaxCyte Inc. visualizedWeekly Profit Report & Technical Buy Zone Confirmations - Newser
Multi asset correlation models including MaxCyte Inc.Market Growth Report & Weekly High Potential Stock Alerts - Newser
MaxCyte Inc. stock trendline breakdown2025 Risk Factors & Smart Money Movement Alerts - Newser
Why is MaxCyte Inc. stock going downAnalyst Downgrade & Real-Time Price Movement Reports - خودرو بانک
Applying Elliott Wave Theory to MaxCyte Inc.Chart Signals & Reliable Entry Point Alerts - Newser
Momentum divergence signals in MaxCyte Inc. chartCEO Change & Free Community Consensus Stock Picks - Newser
What is the target price for MaxCyte Inc. stock2025 Market Trends & Fast Moving Stock Trade Plans - 뉴스영
Applying chart zones and confluence areas to MaxCyte Inc.2025 Key Lessons & Risk Controlled Stock Alerts - Newser
Can MaxCyte Inc. hit a new high this month2025 Big Picture & Scalable Portfolio Growth Ideas - Newser
How to use Fibonacci retracement on MaxCyte Inc.Trade Risk Assessment & Daily Volume Surge Signals - Newser
How to recover losses in MaxCyte Inc. stockDip Buying & Fast Gain Swing Trade Alerts - Newser
Measuring MaxCyte Inc.’s beta against major indicesPortfolio Profit Report & AI Enhanced Trading Alerts - Newser
How to integrate MaxCyte Inc. into portfolio analysis tools2025 Year in Review & Growth Oriented Trade Recommendations - Newser
What’s the recovery path for long term holders of MaxCyte Inc.July 2025 Breakouts & Free Reliable Trade Execution Plans - Newser
Will MaxCyte Inc. price bounce be sustainableMarket Performance Report & Stock Portfolio Risk Control - Newser
What’s next for MaxCyte Inc. stock priceInsider Buying & Accurate Entry/Exit Alerts - Newser
Signal strength of MaxCyte Inc. stock in tech scannersMarket Growth Report & Community Consensus Picks - Newser
Visual analytics tools that track MaxCyte Inc. performanceInsider Buying & Verified Entry Point Detection - Newser
Should value investors consider MaxCyte Inc.Weekly Volume Report & Reliable Entry Point Trade Alerts - خودرو بانک
Using economic indicators to assess MaxCyte Inc. potential2025 Stock Rankings & Real-Time Chart Pattern Alerts - Newser
How hedge fund analytics apply to MaxCyte Inc. stockPortfolio Gains Summary & Fast Exit Strategy with Risk Control - Newser
Is it too late to sell MaxCyte Inc.2025 Historical Comparison & AI Based Buy and Sell Signals - Newser
Can MaxCyte Inc. continue delivering strong returnsTrade Analysis Report & Free Fast Gain Swing Trade Alerts - خودرو بانک
Is MaxCyte Inc. attractive for institutional investors2025 Market Overview & Smart Swing Trading Alerts - خودرو بانک
Is MaxCyte Inc. on track to beat earningsWeekly Stock Analysis & Real-Time Market Trend Scan - خودرو بانک
Technical signs of recovery in MaxCyte Inc.July 2025 Sentiment & Free Risk Controlled Daily Trade Plans - Newser
Relative strength of MaxCyte Inc. in sector analysis2025 Major Catalysts & Daily Volume Surge Trade Alerts - Newser
Published on: 2025-09-02 00:49:26 - Newser
How does MaxCyte Inc. score in quality rankingsWeekly Earnings Recap & Reliable Price Breakout Alerts - خودرو بانک
Analyzing recovery setups for MaxCyte Inc. investors2025 Winners & Losers & Detailed Earnings Play Strategies - Newser
Is MaxCyte Inc. a top pick in the sector2025 Support & Resistance & AI Powered Market Trend Analysis - خودرو بانک
MaxCyte Inc. stock chart pattern explainedWeekly Profit Recap & Verified Technical Trade Signals - Newser
Fibonacci Support Holding Strong in MaxCyte Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스
What to expect from MaxCyte Inc. in the next 30 days2025 Biggest Moves & Fast Moving Market Watchlists - Newser
Maxcyte Inc Stock (MXCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.14%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):